FDA
- Status: approved
🇺🇸 sIPV batch 2 in United States
sIPV batch 2 (sIPV batch 2) regulatory status in United States.
Marketing authorisation
sIPV batch 2 in other countries
Same drug, different regulators. Each page below lists the local marketing authorisation, HTA position, pricing, and adverse-event data.
Frequently asked questions
Is sIPV batch 2 approved in United States?
Yes. FDA has authorised it.
Who is the marketing authorisation holder for sIPV batch 2 in United States?
Institute of Medical Biology, Chinese Academy of Medical Sciences is the originator. The local marketing authorisation holder may differ — check the official source linked above.